A carregar...
Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine Efficacy
Buruli ulcer (BU) vaccine design faces similar challenges to those observed during development of prophylactic tuberculosis treatments. Multiple BU vaccine candidates, based upon Mycobacterium bovis BCG, altered Mycobacterium ulcerans (MU) cells, recombinant MU DNA, or MU protein prime-boosts, have...
Na minha lista:
Publicado no: | PLoS Negl Trop Dis |
---|---|
Main Authors: | , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Public Library of Science
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5179062/ https://ncbi.nlm.nih.gov/pubmed/27941982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0005229 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|